In April 2026, researchers at the 23andMe Research Institute published a large genetic study in Nature examining why people respond so differently to GLP-1 For many people using Wegovy, reaching the standard maintenance dose of 2.4mg can lead to significant weight loss and improvements in overall health
When GLP-1 medications aren't accessible for patients whose insurance doesn't cover GLP-1s, or who prefer not to take injections, phentermine provides a clinically meaningful alternative at a fraction of the cost
After weeks of legal drama, Ozempic is coming Hims & Hers, a telehealth company
HNF-4, Hepatocyte nuclear factor 4 alpha
To assess the role of this pathway in 1% O LCLs, we treated cells with simvastatin, an HMG-CoA reductase (HMGCR) inhibitor, which blocked the mevalonate pathway (S8C Fig)